Cassava Sciences shares are trading higher after the company announced it will enter into a settlement agreement with the SEC. Also, HC Wainwright & Co upgraded the stock from Neutral to Buy and announced a $116 price target.
Portfolio Pulse from Benzinga Newsdesk
Cassava Sciences shares rise as the company settles with the SEC and receives an upgrade from HC Wainwright & Co, which set a $116 price target.
October 08, 2024 | 2:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cassava Sciences shares are trading higher following a settlement agreement with the SEC and an upgrade from HC Wainwright & Co, which set a $116 price target.
The settlement with the SEC removes a legal overhang, potentially reducing investor uncertainty. The upgrade from HC Wainwright & Co to 'Buy' with a $116 price target is a strong positive signal, likely boosting investor confidence and driving the stock price higher.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100